These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

537 related items for PubMed ID: 11786693

  • 1. Testosterone deficiency and replacement.
    Howell S, Shalet S.
    Horm Res; 2001; 56 Suppl 1():86-92. PubMed ID: 11786693
    [Abstract] [Full Text] [Related]

  • 2. Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men.
    Traish AM.
    Adv Exp Med Biol; 2017; 1043():473-526. PubMed ID: 29224108
    [Abstract] [Full Text] [Related]

  • 3. Randomized placebo-controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy.
    Howell SJ, Radford JA, Adams JE, Smets EM, Warburton R, Shalet SM.
    Clin Endocrinol (Oxf); 2001 Sep; 55(3):315-24. PubMed ID: 11589674
    [Abstract] [Full Text] [Related]

  • 4. Testosterone replacement therapy in male hypogonadism.
    Byrne M, Nieschlag E.
    J Endocrinol Invest; 2003 May; 26(5):481-9. PubMed ID: 12906378
    [Abstract] [Full Text] [Related]

  • 5. Testosterone treatment in the aging male: myth or reality?
    Nigro N, Christ-Crain M.
    Swiss Med Wkly; 2012 May; 142():w13539. PubMed ID: 22430839
    [Abstract] [Full Text] [Related]

  • 6. Current topics in testosterone replacement of hypogonadal men.
    Nieschlag E.
    Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):77-90. PubMed ID: 25617174
    [Abstract] [Full Text] [Related]

  • 7. Testosterone supplementation: what and how to give.
    Jockenhövel F.
    Aging Male; 2003 Sep; 6(3):200-6. PubMed ID: 14628500
    [Abstract] [Full Text] [Related]

  • 8. Testosterone hormone replacement therapy: state-of-the-art and emerging technologies.
    Leichtnam ML, Rolland H, Wüthrich P, Guy RH.
    Pharm Res; 2006 Jun; 23(6):1117-32. PubMed ID: 16755346
    [Abstract] [Full Text] [Related]

  • 9. [Testosterone substitution in patients with hypogonadism].
    Martínez Portillo FJ, Cueva Martínez A, Martin Braun P, Fernández Arancibia MI, Jünemann KP, Alken P.
    Arch Esp Urol; 2002 Sep; 55(7):827-38. PubMed ID: 12380312
    [Abstract] [Full Text] [Related]

  • 10. Testosterone supplementation therapy for older men: potential benefits and risks.
    Gruenewald DA, Matsumoto AM.
    J Am Geriatr Soc; 2003 Jan; 51(1):101-15; discussion 115. PubMed ID: 12534854
    [Abstract] [Full Text] [Related]

  • 11. Current and future testosterone delivery systems for treatment of the hypogonadal male.
    Pfeil E, Dobs AS.
    Expert Opin Drug Deliv; 2008 Apr; 5(4):471-81. PubMed ID: 18426387
    [Abstract] [Full Text] [Related]

  • 12. Bone mineral density outcomes following long-term treatment with subcutaneous testosterone pellet implants in male hypogonadism.
    Zacharin MR, Pua J, Kanumakala S.
    Clin Endocrinol (Oxf); 2003 Jun; 58(6):691-5. PubMed ID: 12780744
    [Abstract] [Full Text] [Related]

  • 13. Testosterone and body functions.
    Köhn FM.
    Aging Male; 2006 Dec; 9(4):183-8. PubMed ID: 17178552
    [Abstract] [Full Text] [Related]

  • 14. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men.
    Wang C, Swerdloff RS, Iranmanesh A, Dobs A, Snyder PJ, Cunningham G, Matsumoto AM, Weber T, Berman N, Testosterone Gel Study Group.
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2839-53. PubMed ID: 10946892
    [Abstract] [Full Text] [Related]

  • 15. Double-blind placebo-controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism.
    Merza Z, Blumsohn A, Mah PM, Meads DM, McKenna SP, Wylie K, Eastell R, Wu F, Ross RJ.
    Int J Androl; 2006 Jun; 29(3):381-91. PubMed ID: 16390499
    [Abstract] [Full Text] [Related]

  • 16. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.
    Wang C, Cunningham G, Dobs A, Iranmanesh A, Matsumoto AM, Snyder PJ, Weber T, Berman N, Hull L, Swerdloff RS.
    J Clin Endocrinol Metab; 2004 May; 89(5):2085-98. PubMed ID: 15126525
    [Abstract] [Full Text] [Related]

  • 17. Testosterone therapy--what, when and to whom?
    Jockenhövel F.
    Aging Male; 2004 Dec; 7(4):319-24. PubMed ID: 15799128
    [Abstract] [Full Text] [Related]

  • 18. Three-year follow-up of androgen treatment in hypogonadal men: preliminary report with testosterone gel.
    Swerdloff RS, Wang C.
    Aging Male; 2003 Sep; 6(3):207-11. PubMed ID: 14628501
    [Abstract] [Full Text] [Related]

  • 19. Effects of testosterone replacement in hypogonadal men.
    Snyder PJ, Peachey H, Berlin JA, Hannoush P, Haddad G, Dlewati A, Santanna J, Loh L, Lenrow DA, Holmes JH, Kapoor SC, Atkinson LE, Strom BL.
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2670-7. PubMed ID: 10946864
    [Abstract] [Full Text] [Related]

  • 20. Effects of testosterone replacement in androgen-deficient women with hypopituitarism: a randomized, double-blind, placebo-controlled study.
    Miller KK, Biller BM, Beauregard C, Lipman JG, Jones J, Schoenfeld D, Sherman JC, Swearingen B, Loeffler J, Klibanski A.
    J Clin Endocrinol Metab; 2006 May; 91(5):1683-90. PubMed ID: 16478814
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.